Mounjaro 2.5mg

Description

Mounjaro® (Tirzepatide) – an innovative drug for weight control and treatment of type 2 diabetes

Mounjaro is a modern injection drug from Eli Lilly, developed for the treatment of type 2 diabetes and weight loss. It has become a revolution in endocrinology and dietetics due to its unique formula and high efficiency.

Active ingredient

Tirzepatide is an innovative dual agonist of GIP and GLP-1 receptors.

Unlike classical drugs that affect only GLP-1, Mounjaro simultaneously stimulates two pathways of glucose regulation and metabolism, which makes it much more effective in controlling weight and blood sugar levels.

Main effects of Mounjaro

• Weight loss – in clinical studies, patients lost up to 15–22% of their weight in 72 weeks.
• Stabilization of sugar levels – improves tissue sensitivity to insulin and reduces HbA1c.
• Appetite control – reduces hunger and cravings for overeating.
• Support for heart and vascular health – helps normalize cholesterol levels and reduces the risk of complications.

Release form

Pre-filled disposable syringe pens for subcutaneous administration.

Available dosages: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg.

Packaging: 4 syringe pens for 1 month of therapy.

Indications for use

Treatment of type 2 diabetes as part of complex therapy.

Weight loss in patients with obesity or overweight (BMI ≥ 27).

Method of administration

The drug is administered subcutaneously once a week, regardless of food intake.

Injection sites: abdomen, thigh or shoulder.

The dosage is selected individually and gradually increased under the supervision of a doctor.

Contraindications and side effects

Contraindications:

Individual intolerance to the components

History of medullary thyroid cancer

Multiple endocrine neoplasia syndrome (MEN2)

Possible side effects:

• nausea, diarrhea, constipation
• mild loss of appetite
• rarely – pancreatitis or hypoglycemia
• Why Mounjaro has become popular all over the world
• High efficiency in weight loss without strict diets
• Unique dual technology of action on GIP and GLP-1
• Ease of use – one injection per week
• Clinically proven safety

*The product has contraindications. We are not responsible for any negative consequences that you may encounter after self-use of the product. Before any procedure, it is recommended to consult a doctor or medical specialist.